Changes in Mycobacterium tuberculosis genotype families over 20 years in a population-based study in Northern Malawi.
BACKGROUND
Despite increasing interest in possible differences in virulence and transmissibility between different genotypes of M. tuberculosis, very little is known about how genotypes within a population change over decades, or about relationships to HIV infection.


RESULTS
In a population-based study in rural Malawi we have examined smears and cultures from tuberculosis patients over a 20-year period using spoligotyping. Isolates were grouped into spoligotype families and lineages following previously published criteria. Time trends, HIV status, drug resistance and outcome were examined by spoligotype family and lineage. In addition, transmissibility was examined among pairs of cases with known epidemiological contact by assessing the proportion of transmissions confirmed for each lineage, on the basis of IS6110 RFLP similarity of the M tuberculosis strains. 760 spoligotypes were obtained from smears from 518 patients from 1986-2002, and 377 spoligotypes from cultures from 347 patients from 2005-2008. There was good consistency in patients with multiple specimens. Among 781 patients with first episode tuberculosis, the majority (76%) had Lineage 4 ("European/American") strains; 9% had Lineage 3 ("East-African/Indian"); 8% Lineage 1 ("Indo-Oceanic"); and 2% Lineage 2 ("East-Asian"); others unclassifiable. Over time the proportion of Lineage 4 decreased from >90% to 60%, with an increase in the other 3 lineages (p<0.001). Lineage 1 strains were more common in those with HIV infection, even after adjusting for age, sex and year. There were no associations with drug resistance or outcome, and no differences by lineage in the proportion of pairs in which transmission was confirmed.


CONCLUSIONS
This is the first study to describe long term trends in the four M. tuberculosis lineages in a population. Lineage 4 has probably been longstanding in this population, with relatively recent introductions and spread of Lineages1-3, perhaps influenced by the HIV epidemic.
Glynn
Judith R
JR
London School of Hygiene & Tropical Medicine, London, United Kingdom. judith.glynn@lshtm.ac.uk
Alghamdi
Saad
S
Mallard
Kim
K
McNerney
Ruth
R
Ndlovu
Richard
R
Munthali
Lumbani
L
Houben
Rein M
RM
Fine
Paul E M
PE
French
Neil
N
Crampin
Amelia C
AC
D046508:Culture Techniques; D024881:Drug Resistance, Bacterial; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000150:complications; D006801:Humans; D008295:Malawi / Q000453:epidemiology; D008297:Male; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics*; D013183:Sputum / Q000382:microbiology; D013997:Time Factors; D016896:Treatment Outcome; D014376:Tuberculosis / Q000150:complications / Q000453:epidemiology / Q000628:therapy
Emerg Infect Dis. 2005 Jan;11(1):150-3
15705343
BMC Microbiol. 2006 Mar 06;6:23
16519816
J Clin Microbiol. 1997 Apr;35(4):907-14
9157152
Nature. 2004 Sep 2;431(7004):84-7
15343336
J Infect Dis. 2005 Aug 1;192(3):480-7
15995962
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15594-8
17028173
Lancet Infect Dis. 2007 May;7(5):328-37
17448936
Emerg Infect Dis. 2008 Jul;14(7):1060-6
18598626
Int J Tuberc Lung Dis. 2001 Mar;5(3):216-9
11326819
J Infect Dis. 1999 Oct;180(4):1238-44
10479153
Emerg Infect Dis. 2010 Feb;16(2):272-80
20113558
AIDS. 2004 Jul 2;18(10):1459-63
15199323
Int J Tuberc Lung Dis. 2007 Mar;11(3):311-8
17352098
Tuberculosis (Edinb). 2009 May;89(3):203-9
19251482
PLoS One. 2009 Nov 12;4(11):e7815
19915672
Trans R Soc Trop Med Hyg. 2009 Dec;103(12):1187-9
19362727
Lancet Infect Dis. 2010 Feb;10(2):103-11
20113979
Clin Infect Dis. 2008 Nov 15;47(10):1252-9
18834315
J Clin Microbiol. 2004 Oct;42(10):4536-44
15472306
J Infect Dis. 1998 Apr;177(4):1107-11
9534994
Infect Genet Evol. 2008 Jul;8(4):474-83
18024233
Emerg Infect Dis. 2006 May;12(5):729-35
16704828
Mol Pathol. 1998 Aug;51(4):209-14
9893747